NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Transgene SA (PA: TNG)

 
TNG Technical Analysis
1.5
As on 17th Sep 2025 TNG STOCK Price closed @ 1.15 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.98 & Sell for SHORT-TERM with Stoploss of 1.26 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

TNGSTOCK Price

Open 1.10 Change Price %
High 1.20 1 Day 0.05 4.55
Low 1.10 1 Week 0.06 5.50
Close 1.15 1 Month 0.12 11.65
Volume 187677 1 Year -0.30 -20.69
52 Week High 1.48 | 52 Week Low 0.56
 
PA France Most Active Stocks
ALVER 0.00 %
ALEUP 0.00 %
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
LAT 0.01 %
CGG 0.69 -2.82%
ALHYG 0.01 0.00%
ALNRG 0.00 %
ALTBG 2.88 %
VLA 4.20 11.11%
 
PA France Top Gainers Stocks
GNRO 0.05 66.67%
ALMUN 0.76 11.76%
VLA 4.20 11.11%
VLA 4.20 11.11%
ALUCI 0.10 11.11%
ALSTW 73.00 10.61%
MLOCT 0.22 10.00%
MLSRP 40.40 9.78%
MLWEA 1.62 9.46%
2MX 7.46 8.43%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
MLPRX 0.19 -13.64%
ALIMP 0.28 -12.50%
ALNEV 0.28 -12.50%
ORP 7.90 -12.03%
MLMON 0.88 -12.00%
ALSGD 0.08 -11.11%
ALTHX 2.24 -9.31%
 
 
TNG
Daily Charts
TNG
Intraday Charts
Whats New @
Bazaartrend
TNG
Free Analysis
 
TNG Important Levels Intraday
RESISTANCE1.34
RESISTANCE1.28
RESISTANCE1.24
RESISTANCE1.20
SUPPORT1.10
SUPPORT1.06
SUPPORT1.02
SUPPORT0.96
 
TNG Forecast September 2025
4th UP Forecast1.82
3rd UP Forecast1.61
2nd UP Forecast1.47
1st UP Forecast1.34
1st DOWN Forecast0.96
2nd DOWN Forecast0.83
3rd DOWN Forecast0.69
4th DOWN Forecast0.48
 
TNG Weekly Forecast
4th UP Forecast1.77
3rd UP Forecast1.57
2nd UP Forecast1.45
1st UP Forecast1.32
1st DOWN Forecast0.98
2nd DOWN Forecast0.85
3rd DOWN Forecast0.73
4th DOWN Forecast0.53
 
TNG Forecast2025
4th UP Forecast3.06
3rd UP Forecast2.45
2nd UP Forecast2.07
1st UP Forecast1.69
1st DOWN Forecast0.61
2nd DOWN Forecast0.23
3rd DOWN Forecast-0.15
4th DOWN Forecast-0.76
 
 
TNG Other Details
Segment EQ
Market Capital 199123072.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
TNG Address
TNG
 
TNG Latest News
 
Your Comments and Response on Transgene SA
 
TNG Business Profile
Transgene SA, a biotechnology company, focuses on designing and developing therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases. The company is involved in developing TG4050, a therapeutic vaccine that is in phase I clinical trial for the treatment of ovarian cancer, and human papilloma virus (HPV)-negative head and neck cancers; TG4001, a therapeutic vaccine, which is in phase II clinical trial for the treatment of HPV-positive cancers; TG6002, an oncolytic virus that is in phase I/IIa clinical trial for the treatment of various solid tumors, such as gastrointestinal adenocarcinoma (stomach, pancreas, and colon); and BT-001, an oncolytic virus, which is in phase I/II clinical trial for the treatment of solid tumors. It also develops TG1050, a therapeutic vaccine for the treatment of chronic hepatitis B; and Pexa-Vec, an oncolytic virus for the treatment of solid tumors. Transgene SA has strategic collaboration agreements with AstraZeneca, Merck KGaA, Pfizer, and NEC Corporation; licensing agreements with SillaJen, Ascend BioPharmaceutical, and Valneva; and agreements with Sanofi, BioInvent, and Randox. The company was incorporated in 1979 and is headquartered in Illkirch-Graffenstaden, France. Transgene SA is a subsidiary of TSGH SAS. Address: 400, Boulevard Gonthier d?Andernach, Illkirch-Graffenstaden, France, 67405
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service